Rare Disease as an Emerging and Distinct Field of Medicine
Marshall Summar, M.D.
Chief, Division of Genetics and Metabolism
Director, Rare Disease Institute
Magaret O'Malley Chair, Genetic Medicine
Children's National Hospital
Rare Disease as an Emerging and Distinct Field of Medicine
Date: Aug. 30, 2022
Time: 1 - 2 p.m.
About this Seminar
With the completion of the human genome sequence and the advent of affordable molecular sequencing, the field of genetic rare diseases has exploded. With over 8000 conditions described (and counting), the classic expectation of a physicians encyclopedic knowledge of their field is unrealistic. The pace of therapeutic development for rare disease is also explosive with 52% of new drugs approved by the FDA for rare diseases. This lecture will describe this oncoming wave and discuss new models that can be used to care for patients.
You May Also Be Interested In...
-
Home Item
Exercise, the Fountain of Youth? , homeOct. 15, 2026, 5:30 p.m. (Reception at 5 p.m.) | Zhen Yan, Ph.D., Professor and Director, Center for Exercise Medicine Research, Fralin Biomedical Research Institute at VTC | Maury Strauss Distinguished Public Lecture
-
Home Item
Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies , homeOct. 16, 2026, 11:00 a.m. | Peng Jiang, Ph.D., Senior Investigator, National Cancer Institute, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute and the Cancer Research Center — D.C.
-
Home Item
Mapping Different Excitatory and Inhibitory Input Types onto Single Cortical Pyramidal Neurons , homeOct. 30, 2026, 11:00 a.m. | Elly Nedivi, Ph.D., William R. (1964) & Linda R. Young Professor of Neuroscience, The Picower Institute for Learning & Memory, Departments of Brain and Cognitive Sciences, and Biology, Massachusetts Institute of Technology | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Neurobiology Research
-
Home Item
Drug Discovery in the Next Decade: From Genome Medicine to Clinical Trial in a Dish , homeNov. 5, 2026, 5:30 p.m. (Reception at 5 p.m.) | Joseph Wu, M.D., Ph.D., Professor and Director, Stanford Cardiovascular Institute, Stanford University School of Medicine | Maury Strauss Distinguished Public Lecture
-
Home Item
Presenting Therapeutic Peptides Using Synthetic Polymers , homeNov. 13, 2026, 11:00 a.m. | Rachel A. Letteri, Ph.D., Associate Professor, Departments of Chemical Engineering, University of Virginia | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research
-
Home Item
The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function , homeDec. 11, 2026, 11:00 a.m. | Paule V. Joseph, Ph.D., MBA, Lasker Clinical Research Scholar, NIH Distinguished Scholar, Acting Chief, Section of Sensory Science and Metabolism Unit, NIDCD; Co-Director, National Smell and Taste Center; Attending Nurse Practitioner, Division of Intramural Clinical and Biological Research; National Institute on Alcohol Abuse and Alcoholism, National Institute on Deafness and Other Communication Disorders | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research